Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 7;4(15):3648–3658. doi: 10.1182/bloodadvances.2020002270

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by The American Society of Hematology

PMC Copyright notice

Figure 1. — Examples of responses to R-CHOP preceded by NGR-hTNF. (A) Gadolinium-enhanced T1-weighted scan shows a large homogeneous enhancing lesion in the right parietal lobe (arrows) in a 65-year-old man at second relapse after high-dose methotrexate and after salvage high-dose ifosfamide-based therapy plus WBRT. (B) Tumor regression after 4 courses of experimental treatment. (C) Gadolinium-enhanced T1-weighted scan shows a large polylobate, enhancing lesion infiltrating the basal ganglia, diencephalon, and left temporal lobe (arrows) in a 39-year-old man with PCNSL refractory to previous high-dose methotrexate-based chemoimmunotherapy. (D) Tumor regression after 4 courses of experimental treatment.